CA
SNY icon

Crewe Advisors’s Sanofi SNY Stock Holding History

Crewe Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34
Closed -$1.64K – 1192
2026
Q1 		$1.64K Hold
34
– – ﹤0.01% 919
2025
Q4 		$1.65K Hold
34
– – ﹤0.01% 915
2025
Q3 		$1.6K Sell
34
-35
-51% -$1.69K ﹤0.01% 871
2025
Q2 		$3.33K Buy
69
+47
+214% +$2.4K ﹤0.01% 555
2025
Q1 		$1.22K Buy
+22
New +$1.19K ﹤0.01% 578
2023
Q2 		– Sell
-355
Closed -$19.3K – 991
2023
Q1 		$19.3K Hold
355
– – ﹤0.01% 439
2022
Q4 		$17.2K Hold
355
– – ﹤0.01% 447
2022
Q3 		$13K Hold
355
– – ﹤0.01% 591
2022
Q2 		$18K Buy
+355
New +$18.8K ﹤0.01% 453
2020
Q4 		– Sell
-128
Closed -$6K – 626
2020
Q3 		$6K Buy
+128
New +$6.59K ﹤0.01% 341

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Crewe Advisors's SNY Position: Q2 2026 in Review

Crewe Advisors sold out of Sanofi (SNY) in Q2 2026, closing a stake of 34 shares — an estimated $1.64K sold.

Crewe Advisors first reported a position in SNY in Q3 2020 and held it in 10 quarters. The position peaked at $19.3K in Q1 2023. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Crewe Advisors reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Crewe Advisors sold 34 Sanofi shares in Q2 2026, an estimated $1.64K.
  • Crewe Advisors first reported a position in Sanofi in Q3 2020 and held it in 10 quarters.
  • Crewe Advisors's Sanofi position peaked at $19.3K in Q1 2023.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.